Buy & Sell 22nd Century Group Inc (XXII) – 22nd Century Group Inc Price Today
Aura AI Summary
Key Stats
- $1.60MMarket Cap
- TechnologySector
- -93.38%3M Drawdown
- -$6.63MEnterprise Value
- -Dividend Yield
- 13 daysTypical Hold Time
22nd Century Group Inc (XXII) is currently valued at a market capitalization of $1.60M, with an enterprise value of -$6.63M. Over the past 52 weeks, 22nd Century Group Inc has traded between a low of $4.65 and a high of $2,616, highlighting its annual price range. Over the past three months, 22nd Century Group Inc has recorded a drawdown of -93.38%, reflecting recent price volatility. On average, investors hold 22nd Century Group Inc for approximately 13 days, indicating typical investor behavior on the platform.
About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Most Recent News
Oil prices rise after US threatens military action on Iran amid fragile peace talks.
Oil prices increased following US President Trump's threat of renewed military action against Iran, despite ongoing peace talks between US and Iranian officials in Switzerland. The threat and Iran's closure of the Strait of Hormuz, a vital oil shippi...

Getty Images partners with OpenAI to integrate licensed visuals into ChatGPT for richer AI responses
Getty Images has entered a multi-year display partnership with OpenAI to feature its licensed visual content within ChatGPT's search and discovery functions. This collaboration aims to enhance the quality and trustworthiness of AI-powered visual resp...

Abaxx denies regulatory probes, refutes misinformation, and highlights strong cash reserves amid trading allegations.
Abaxx Technologies has denied any regulatory investigations and refuted claims made by Viceroy Research, which it calls a short-and-distort campaign aimed at driving down its stock price. The company has engaged regulators in Canada and Singapore to ...
